期刊文献+

转录因子8在肿瘤血管发生过程中作用初探 被引量:1

Role of Transcription Factor 8 in the Regulation of Tumor Angiogenesis
下载PDF
导出
摘要 目的研究转录因子8(TCF8)在肿瘤血管生成过程中的作用。方法通过siRNA转染敲除人脐静脉血管内皮细胞(HUVECs)中的TCF8,通过实时PCR和Weston blot检测转染后的HUVECs中TCF8 mRNA和蛋白的表达情况,并通过体外小管形成实验观察TCF8被敲除后对HUVECs管腔形成能力的影响。结果siTCF8转染HUVECs 72 h后TCF8的RNA和蛋白表达水平siTCF8组明显低于sicontrol组(P<0.05);体外小管形成实验显示siTCF8组形成后的多数管腔不完整,其完整管腔数量形成明显少于sicontrol组(P<0.05)。结论应用RNA干扰技术可有效干扰TCF8的表达,敲除TCF8可以抑制肿瘤血管形成,TCF8有可能成为临床上抗肿瘤血管生成治疗的新靶点。 Objective To investigate the role of transcription Factor 8 (TCF8) in the regulation of tumor angiogenesis. Methods TCF8 of the human umbilical vascular endothelial ceils (HUVECs) was knocked down by siRNA. The RNA and protein expressions of TCF8 were detected in HUVECs which were transfected by real-time PCR and Western blot. And the role of TCF8 in tumor angiogenesis was observed by the tube formation assay. Results The RNA and protein expressions of TCF8 in the siTCF8 group were lower than those of the sicontrel group ( P 〈 0.05 ). The vasculatures of the siTCF8 group were unsettled and leaky, and the number of the settled vasculatures was lower than that of the sicontrol group by the tube formation assay ( P 〈 0.05 ). Conclusion RNA interference can effectively inhibit the expression of TCF8, knocking down TCF8 in endothelial cells can depress the formation of new tumor vessel, suggesting that TCF8 might be a good target for the anti-angiogenesis treatment of cancer in clinical medicine.
出处 《肿瘤基础与临床》 2013年第4期282-284,共3页 journal of basic and clinical oncology
基金 河南省教育厅科学技术重点研究项目(编号:13A310553)
关键词 转录因子8 肿瘤血管发生 人脐静脉血管内皮细胞 RNA干扰 SIRNA transcription factor 8 tumor angiogenesis human umbilical vascular endothelial cells RNA interference siRNA
  • 相关文献

参考文献7

  • 1Al-Husein B,Abdalla M ,Trepte M,et al. Antiangiogenic therapy forcancer : an update [ J ]. Pharmacotherapy,2012,32 ( 12 ) : 1095-1111.
  • 2Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors intumour progression : an alliance against the epithelial phenotype[J].Nat Rev Cancer,2007,7(6) :415 -428.
  • 3Karademir S,Sokmen S,Terzi C, et al. Tumor angiogenesis as aprognostic predictor in pancreatic cancer[ J]. J Hepatobiliary Pan-creat Surg,2000,7(5) :489 -495.
  • 4Sitohy B, Nagy JA, Dvorak HF. Anti-VEGF/VEGFR therapy forcancer: reassessing the target[ J] . Cancer Res,2012, 72(8) :1909-1914.
  • 5Sav A,Rotondo F,Syro LV,et al. Biomarkers of pituitary neoplasms[J]. Anticancer Res,2012,32( 11) :4639 -4654.
  • 6Vandewalle C, Van Roy F, Berx G. The role of the ZEB family oftranscription factors in development and disease [ J ]. Cell Mol LifeSci,2009,66(5) :773 -787.
  • 7Smit MA,Peeper DS. Zebl is required for TrkB-induced epithelial-mesenchymal transition, anoikis resistance and metastasis [ J ] . On-cogene,2011,30(35) :3735 -3744.

同被引文献5

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部